Renal Allograft Protection with Angiotensin II Type 1 Receptor Antagonists L.
Open Access
- 1 January 2007
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (1) , 243-248
- https://doi.org/10.1111/j.1600-6143.2006.01588.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Renal Protective Effects of the Renin-Angiotensin-Aldosterone System Blockade: From Evidence-Based Approach to PerspectivesKidney and Blood Pressure Research, 2005
- Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathyTransplant International, 2004
- Effect of Angiotensin II Receptor Blocker on Plasma Levels of TGF-β1 and Interstitial Fibrosis in Hypertensive Kidney Transplant PatientsAmerican Journal of Nephrology, 2003
- Treatment of hypertension in renal transplant recipientsCurrent Opinion in Urology, 2003
- Oxidative stress and TGFb in kidney- transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipineClinical Nephrology, 2002
- Renoprotective effects of carvedilol in hypertensive‐stroke prone rats may involve inhibition of TGFβ expressionBritish Journal of Pharmacology, 2001
- CHANGES OF URINARY ??1-MICROGLOBULIN IN THE ASSESSMENT OF PROGNOSIS IN RENAL TRANSPLANT RECIPIENTS1Transplantation, 2000
- The Consequences of Tubulo-Interstitial Changes for Renal Function in GlomerulopathiesPathology - Research and Practice, 1990
- Urinary enzymes, nephrotoxicity and renal diseaseToxicology, 1982
- Rapid colorimetric assay of β-galactosidase and N-acetyl-β-glucosaminidase in human urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1976